LAVA Therapeutics N.V. (LVTX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    LAVA Therapeutics N.V.

    NASDAQ: LVTX · Real-Time Price · USD
    1.59
    0.00 (0.12%)
    At close: Sep 26, 2025, 1:16 PM

    LAVA Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 11.98M 6.77M 19.39M 5.35M
    Cost of Revenue
    		 n/a 3.48M n/a n/a
    Gross Profit
    		 11.98M 3.29M 19.39M 5.35M
    Operating Income
    		 -29.69M -43.25M -34.84M -43.61M
    Interest Income
    		 3.76M 3.67M 339K n/a
    Pretax Income
    		 -24.48M -41.7M -31.66M -42.2M
    Net Income
    		 -25.11M -41.97M -31.91M -42.35M
    Selling & General & Admin
    		 13.22M 12.73M 14.12M 12.02M
    Research & Development
    		 28.45M 33.81M 40.1M 36.95M
    Other Expenses
    		 -24.55M n/a n/a n/a
    Operating Expenses
    		 17.13M 46.54M 54.23M 46.92M
    Interest Expense
    		 515K 470K 82K 625K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 41.67M 50.02M 54.23M 46.92M
    Income Tax Expense
    		 630K 279K 249K 157K
    Shares Outstanding (Basic)
    		 26.83M 26.73M 25.92M 19.76M
    Shares Outstanding (Diluted)
    		 26.83M 26.73M 25.92M 19.76M
    EPS (Basic)
    		 -0.94 -1.57 -1.23 -2.14
    EPS (Diluted)
    		 -0.94 -1.57 -1.23 -2.14
    EBITDA
    		 -23.5M -40.53M -30.88M -41.02M
    EBIT
    		 -23.97M -41.14M -31.66M -41.57M
    Depreciation & Amortization
    		 467K 612K 781K 331K

    Add to Watchlist